Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novuspharma antitumor agents particularly effective against solid tumors

Sep. 12, 2001

Targeted apoptosis research program at Antisoma expanded by newly acquired rights from NIH

Sep. 12, 2001

FDA panel emits positive recommendation for Zevalin

Sep. 12, 2001

Clinical trial of Cur-61414 commences for treatment of sporadic BCC

Sep. 12, 2001

Joint Onco TCS clinical development program expanded

Sep. 12, 2001

WHI-P131: a dual-acting antileukemic, anti-GVHD compound targeting JAK3

Sep. 10, 2001

HGS initiates new clinical trial with repifermin for treatment of mucositis

Sep. 10, 2001

Simplified salicylihalimide analogues which retain antitumor activity

Sep. 10, 2001

Modified second-generation taxoids: design and SAR discussed at ACS

Sep. 10, 2001

SCRAS patents new series of somatostatin receptor ligands

Sep. 7, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...